# Real World Study With Benralizumab in Severe Asthma in Switzerland

> **NCT03907137** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 79 (actual)

## Conditions studied

- Severe Eosinophilic Asthma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03907137
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-21
- **Primary completion:** 2023-01-04
- **Final completion:** 2023-01-04
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2024-02-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03907137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03907137, "Real World Study With Benralizumab in Severe Asthma in Switzerland". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03907137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*